Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Scinai Immunotherapeutics Ltd. - American Depositary Shares (NQ:SCNI)

2.500 -0.220 (-8.09%)
Streaming Delayed Price Updated: 3:58 PM EDT, Jun 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,376
Open 2.720
Bid (Size) 2.550 (1)
Ask (Size) 2.990 (2)
Prev. Close 2.720
Today's Range 2.500 - 2.720
52wk Range 1.900 - 8.920
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q1 Revenue Growth Driven by CDMO Contracts, Net Loss Narrows
Via Investor Brand Network
BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports $4.8 Million Net Gain in 2024, Driven by Loan-to-Equity Conversion
Via Investor Brand Network

Performance

YTD
-27.3%
-27.3%
1 Month
+2.5%
+2.5%
3 Month
-28.6%
-28.6%
6 Month
-29.2%
-29.2%
1 Year
-33.3%
-33.3%

More News

Read More
BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Host Webinar on PC111 Antibody for Rare Skin Disorders
Via Investor Brand Network
InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Option Agreement to Acquire Italian Biotech Pincell
Via Investor Brand Network
Cases of Parvovirus B19 Spike in the US
Via Investor Brand Network
New Drug Approach Could Roll Back Pancreatic Cancer Immunotherapy Resistance
Via Investor Brand Network
InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Present at BIO-Europe Spring 2025
Via Investor Brand Network
BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters $10 Million Standby Equity Purchase Agreement
Via Investor Brand Network
Layoffs, Upheaval at CDC Trigger Fears on Handling Disease Outbreaks
Via Investor Brand Network
Topics Government Workforce
Exposures Layoff Political
Biomaterial Modification Could Yield Better Cancer Therapies, Study Finds
Via Investor Brand Network
New Trump Admin Could Drastically Change Research on Infectious Diseases
Via Investor Brand Network
Topics Government
Exposures Political
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Engage Investors and Partners at Key January Conferences
Via Investor Brand Network
Researchers Identify Protein That Makes Cancer Evade Cell Therapy
Via Investor Brand Network
BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Expands CDMO Operations with New U.S. Subsidiary
Via Investor Brand Network
BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Strategic Board Appointment
Via Investor Brand Network
BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Welcomes Dr. Jonathan Sadeh to Scientific Advisory Board
Via Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Nine-Month Financial Results and Business Update
Via Investor Brand Network
New Toolkit Launched to Boost Marburg Screening Readiness in the US
Via Investor Brand Network
BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Spotlight Innovative I&I Pipeline and CDMO Services at BIO-Europe 2024
Via Investor Brand Network
Researchers Shine Spotlight on New Barriers to Vaccination
Via Investor Brand Network
Exposures COVID-19
Whooping Cough Prevalence Rises in US as Missed Shots During Pandemic Come Home to Roost
Via Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Schedules Virtual Panel Discussion on Plaque Psoriasis, Its Promising Novel Solution
Via Investor Brand Network

Frequently Asked Questions

Is Scinai Immunotherapeutics Ltd. - American Depositary Shares publicly traded?
Yes, Scinai Immunotherapeutics Ltd. - American Depositary Shares is publicly traded.
What exchange does Scinai Immunotherapeutics Ltd. - American Depositary Shares trade on?
Scinai Immunotherapeutics Ltd. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Scinai Immunotherapeutics Ltd. - American Depositary Shares?
The ticker symbol for Scinai Immunotherapeutics Ltd. - American Depositary Shares is SCNI on the Nasdaq Stock Market
What is the current price of Scinai Immunotherapeutics Ltd. - American Depositary Shares?
The current price of Scinai Immunotherapeutics Ltd. - American Depositary Shares is 2.500
When was Scinai Immunotherapeutics Ltd. - American Depositary Shares last traded?
The last trade of Scinai Immunotherapeutics Ltd. - American Depositary Shares was at 06/02/25 03:58 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.